Anaesthesiology and Intensive Care Medicine · MU Plovdiv

32. Transfusion therapy - indications, risks and iatrogenic events.

Inside: 6 sections · 1 table · 19 flashcards · 10 min

Essay 32 of 47 in the MU Plovdiv syllabus for Anaesthesiology and Intensive Care Medicine (Medicine, Year 5). The free AceMed note covers it in 6 sections, about 1,149 words (10 min of reading), with 19 flashcards.

In this note

  1. In brief
  2. Transfusion therapy: indications
  3. Risks and iatrogenic events
  4. Massive transfusion
  5. Exam tips
  6. References

In brief

Based on the essays of Ezhil Ganesan (MU Plovdiv), improved and checked by AceMed

  • Transfusion gives blood components to restore oxygen-carrying capacity, volume or haemostasis; give the component that is missing, for a stated reason. Restrictive policy: red cells when haemoglobin is below about 70 g/L in a stable adult (75–80 g/L in cardiac or orthopaedic surgery and in cardiovascular disease), and always for bleeding according to the clinical picture.
  • Components: red cells, plasma (FFP), platelets, cryoprecipitate (fibrinogen) and, in emergencies, whole blood or factor concentrates. ABO and Rh D compatibility and the bedside identity check prevent the most dangerous event, the acute haemolytic reaction.
  • Risks: haemolytic, febrile, allergic and septic reactions, TRALI and TACO, infection, graft-versus-host disease, and metabolic effects of massive transfusion (citrate, potassium, cold, dilution). Any reaction: stop the transfusion and check the patient’s identity against the unit.

Transfusion therapy: indications

  • Principle of patient blood management: treat anaemia before surgery (iron, B₁₂, folate, erythropoietin), reduce loss (tranexamic acid, cell salvage, careful surgery), and transfuse only when the benefit outweighs the risk.

Red cells (packed red cell concentrate)

  • Restrictive thresholds (AABB 2023; ESAIC patient blood management guidance): Hb below 70 g/L in haemodynamically stable hospitalised and critically ill adults (target 70–90 g/L); below 75 g/L in cardiac surgery and 80 g/L in orthopaedic surgery or pre-existing cardiovascular disease. Trials in sepsis and gastrointestinal bleeding (TRISS, Villanueva) support 70 g/L. In acute coronary syndrome and acute brain injury the best threshold is less certain and a higher one (about 80–100 g/L) is often used.
  • Acute blood loss: transfuse according to the bleeding and haemodynamics, not the first Hb value: loss of over 30–40% of the blood volume (ATLS class III–IV), ongoing bleeding, shock or signs of ischaemia (ECG change, lactate, chest pain).
  • Chronic anaemia: find and treat the cause; transfuse only for symptoms (dyspnoea, angina, syncope) or very low Hb. Bone-marrow failure, haemoglobinopathy, haemato-oncology: regular transfusion by protocol, with irradiated, leucodepleted and extended-phenotype-matched red cells where indicated.
  • Effect: one unit raises Hb by about 10 g/L (1 g/dL) in a 70-kg adult who is not bleeding; give and reassess one unit at a time when stable.

Plasma (fresh frozen plasma)

  • Replaces all clotting factors: bleeding with a coagulopathy (INR or PT above about 1.5, or an abnormal viscoelastic test), massive transfusion, thrombotic thrombocytopenic purpura (plasma exchange), rare single-factor deficiency when no concentrate exists. Dose 10–15 mL/kg (about 3–4 units).

Continue reading free

The whole note, all 6 sections, is free with an AceMed account, with its 19 flashcards. Standard adds flashcard recall, highlights and Ask AI.